Thermodynamic characterization of interleukin-8 monomer binding to CXCR1 receptor N-terminal domain

FEBS Journal

Volumn 274, Issue 1, 2007, Pages 241-251

  Fernando, Harshica ^b   Nagle, Gregg T ^b   Rajarathnam, Krishna ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Interleukin 8; Isothermal titration calorimetry; Monomer; N terminal domain; Thermodynamics

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; INTERLEUKIN 8; MONOMER; TRIMETHYLAMINE;

ANIMAL CELL; ARTICLE; ENTHALPY; ENTROPY; HYDROPHOBICITY; ISOTHERMAL TITRATION CALORIMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; PROTON TRANSPORT; THERMODYNAMICS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CIRCULAR DICHROISM; HUMANS; INTERLEUKIN-8; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RABBITS; RECEPTORS, INTERLEUKIN-8A; THERMODYNAMICS;

EID: 33845599535     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05579.x     Document Type: Article

References (48)

1. Luster AD (2002) The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 14, 129-135.
2. Moser B, Wolf M, Walz A & Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25, 75-84.
3. Loetscher P & Clark-Lewis I (2001) Agonistic and antagonistic activities of chemokines. J Leukoc Biol 69, 881-884.
4. Fernandez EJ & Lolis E (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42, 469-499.
5. Crump MP, Gong JH, Loetscher P, Rajarathnam K, Arenzana-Seisdedos F, Virelizier J-L, Baggiolini M, Sykes BD & Clark-Lewis I (1997) Solution structure and basis for functional activity of stromal derived cell-derived factor-1: dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 16, 6996-7007.
6. Murphy PM (1997) Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34, 311-318.
7. Ahuja SK & Murphy PM (1996) The CXC chemokines growth-regulated oncogene (GRO) α, GROβ, GROγ, neutrophil-activating peptide-2, and epithelial cellderived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271, 20545-20550.
8. Clore GM, Appella E, Yamada M, Matsushima K & Gronenborn AM (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry 29, 1689-1696.
9. Baldwin ET, Weber IT, St Charles R, Xuan JC, Appella E, Yamada M, Matsushima K, Edwards BF, Clore GM & Gronenborn AM (1991) Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci USA 88, 502-506.
10. 1H NMR solution structure of an active interleukin-8 monomer. Biochemistry 34, 12983-12990.
11. Skelton NJ, Quan C, Reilly D & Lowman H (1999) Structure of a CXC chemokine-receptor fragment in complex with interleukin-8. Structure 7, 157-168.
12. Clark-Lewis I, Dewald B, Loetscher M, Moser B & Baggiolini M (1994) Structural requirements for IL-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem 269, 16075-16081.
13. 1H NMR evidence that Glu-38 interacts with the N-terminal domain in interleukin-8. FEBS Lett 399, 43-46.
14. Rajarathnam K, Dewald B, Baggiolini M, Sykes BD & Clark-Lewis I (1999) Disulfide bridges in interleukin-8 probed using non-natural disulfide analogs: dissociation of roles in structure and function. Biochemistry 38, 7653-7658.
15. 1H NMR studies of interleukin-8 analogs: characterization of the domains essential for function. Biochemistry 33, 6623-6630.
16. Lowman HB, Fairbrother WJ, Slagle PH, Kabakoff R, Liu J, Shire S & Hebert CA (1997) Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation. Protein Sci 6, 598-608.
17. Suetomi K, Lu Z, Heck T, Wood TG, Prusak DJ, Dunn KJ & Navarro J (1999) Differential mechanisms of recognition and activation of interleukin-8 receptor subtypes. J Biol Chem 274, 11768-11772.
18. Ji TH, Grossmann M & Ji I (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 273, 17299-17302.
19. Leong SR, Kabakoff RC & Hebert CA (1994) Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J Biol Chem 269, 19343-19348.
20. Attwood MR, Borkakoti N, Bottomley GA, Conway EA, Cowan I, Fallowfield AG, Handa BK, Jones PS, Keech E, Kirtland SJ, et al. (1996) Identification and characterization of an inhibitor of interleukin-8: a receptor based approach. Bioorg Med Chem Lett 6, 1869-1974.
21. Gayle RB, Sleath PR, Srinivason S, Birks CW, Weerawarna KS, Cerretti DP, Kozlosky CJ, Nelson N, Bos TV & Beckmann MP (1993) Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J Biol Chem 268, 7283-7289.
22. Fernando H, Chin C, Rösgen J & Rajarathnam K (2004) Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor. J Biol Chem 279, 36175-36178.
23. Rajagopalan L & Rajarathnam K (2004) Ligand selectivity and affinity of chemokine receptor CXCR1: role of N-terminal domain. J Biol Chem 279, 30000-30008.
24. Rajagopalan L, Rösgen J, Bolen DW & Rajarathnam K (2005) Novel use of an osmolyte to dissect thermodynamic linkages between receptor N-domain folding, ligand binding, and ligand dimerization in a chemokine-receptor system. Biochemistry 44, 12932-12939.
25. Rajarathnam K, Prado GN, Fernando H, Clark-Lewis I & Navarro J (2006) Probing receptor binding activity of interleukin-8 dimer using a disulfide trap. Biochemistry 45, 7882-7888.
26. Leavitt S & Freire E (2001) Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr Opin Struct Biol 11, 560-566.
27. Ye J, Kohli LL & Stone MJ (2000) Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3. J Biol Chem 275, 27250-27257.
28. Mayer KL & Stone MJ (2000) NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2. Biochemistry 39, 8382-8395.
29. Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I & Sykes BD (2002) The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41, 10418-10425.
30. Farzan M, Chung S, Li W, Vasilieva N, Wright PL, Schnitzler CE, Marchione RJ, Gerard C, Gerard NP, Sodroski J & Choe H (2002) Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region. J Biol Chem 277, 40397-40402.
31. Mizoue LS, Bazan JF, Johnson EC & Handel TM (1999) Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry 38, 1402-1414.
32. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M & Clark-Lewis I (1994) Neutrophil activation by monomeric interleukin-8. Science 264, 90-92.
33. Rajarathnam K, Kay CM, Clark-Lewis I & Sykes BD (1997) Characterization of quaternary structure of interleukin-8 and functional implications. Methods Enzymol 287, 89-105.
34. Clark-Lewis I, Schumacher C, Baggiolini M & Moser B (1991) Structure-activity relationship of interleukin-8 determined using chemically synthesized analogs. J Biol Chem 266, 23128-23134.
35. Williams G, Borkakoti N, Bottomley GA, Cowan I, Fallowfield AG, Jones PS, Kirtland SJ, Price GJ & Price L (1996) Mutagenesis studies of interleukin-8. Identification of a second epitope involved in receptor binding. J Biol Chem 271, 9579-9586.
36. Schraufstatter IU, Ma M, Oades ZG, Barritt DS & Cochrane CG (1995) The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A. J Biol Chem 270, 10428-10431.
37. Hébert CA, Chuntharapai A, Smith M, Colby T, Kim J & Horuk R (1993) Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J Biol Chem 268, 18549-18553 (erratum appears in J Biol Chem 269, 16520).
38. Baker BM & Murphy KP (1996) Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry. Biophys J 71, 2049-2055.
39. Parker SL, Parker MS, Sah R & Sallee F (2005) Angiogenesis and rhodopsin-like receptors: a role for N-terminal acidic residues? Biochem Biophys Res Commun 335, 983-992.
40. Prabhu NV & Sharp KA (2005) Heat capacity in proteins. Annu Rev Phys Chem 56, 521-548.
41. Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD & Wishart DS (2003) VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 31, 3316-3319.
42. Wand AJ (2001) Dynamic activation of protein function: a view emerging from NMR spectroscopy. Nat Struct Biol 8, 926-931.
43. Jarymowycz VA & Stone MJ (2006) Fast time scale dynamics of protein backbones: NMR relaxation methods, applications, and functional consequences. Chem Rev 106, 1624-1671.
44. Zidek L, Novotony MV & Stone MJ (1999) Increased protein backbone conformational entropy upon hydrophobic ligand binding. Nat Struct Biol 6, 1118-1121.
45. Murphy KP, Xie D, Garcia KC, Amzel LM & Freire E (1993) Structural energetics of peptide recognition: angiotensin II/antibody binding. Proteins 15, 113-120.
46. Bolen DW & Baskakov IV (2001) The osmophobic effect: natural selection of a thermodynamic force in protein folding. J Mol Biol 310, 955-963.
47. Murphy KP & Freire E (1992) Thermodynamics of structural stability and cooperative folding behavior in proteins. Adv Protein Chem 43, 313-361.
48. Wiseman T, Williston S, Brandts JF & Lin LN (1989) Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 179, 131-137.